Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG:1349)
2.320
+0.060 (2.65%)
Jun 18, 2026, 4:08 PM HKT
-32.95% (1Y)
| Market Cap | 6.64B -7.6% |
| Revenue (ttm) | 744.45M -11.7% |
| Net Income | -173.22M |
| EPS | -0.17 |
| Shares Out | 1.04B |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.03 (1.38%) |
| Ex-Dividend Date | Jul 10, 2025 |
| Volume | 43,753,000 |
| Open | 2.250 |
| Previous Close | 2.260 |
| Day's Range | 2.210 - 2.780 |
| 52-Week Range | 2.200 - 5.290 |
| Beta | 0.09 |
| Analysts | Strong Buy |
| Price Target | 6.78 (+192.24%) |
| Earnings Date | Aug 12, 2026 |